Overview

Supernormal Oxygen Delivery for Patients With Severe Burns

Status:
Not yet recruiting
Trial end date:
2023-06-01
Target enrollment:
Participant gender:
Summary
This is a randomized double-blinded study to investigate in which the groups are designated as the control group and the goal-directed fluid therapy group to further evaluate significant differences in rate of complications during burn surgery.
Phase:
Early Phase 1
Details
Lead Sponsor:
Guangzhou Red Cross Hospital
Treatments:
Dobutamine